What was the primary driver of Elevance Health's revenue growth in 2006?

The primary driver of Elevance Health's revenue growth in 2006 was the acquisition of WellChoice, Inc., completed on December 28, 2005. This acquisition significantly expanded the company's membership and market presence, particularly in New York. Additionally, premium rate increases across various customer segments and new enrollment in Medicare Part D products contributed to the revenue growth.

How did Elevance Health manage healthcare costs in 2006?

Elevance Health focused on managing healthcare costs through a combination of strategies including disciplined underwriting, medical management programs (like precertification and concurrent review), formulary management, and negotiating favorable provider contracts. The company also highlighted its investment in integrated care management programs like '360º Health' and the Blue Health Intelligence initiative to improve care quality and cost-effectiveness.

What is the company's approach to capital allocation, as evidenced by the 2006 filings?

Elevance Health demonstrated a strong commitment to capital allocation in 2006. The company executed a significant stock repurchase program, buying back approximately 60.7 million shares for $4.6 billion, believing it to be a prudent use of surplus capital. Additionally, the company maintained a strong balance sheet and a healthy level of liquidity, with $20.8 billion in cash, cash equivalents, and investments, enabling continued investment in organic growth and strategic opportunities.

What are the key risks highlighted by Elevance Health in its 2006 10-K?

The company identified several key risks, including potential adverse impacts from changes in state and federal regulations, the inability to contain healthcare costs or maintain adequate reserves, intense competition in the managed care industry, and risks associated with participation in Medicare and Medicaid programs. Negative publicity within the health benefits industry was also cited as a potential risk. Furthermore, the significant portion of intangible assets on the balance sheet due to acquisitions, representing a substantial percentage of total assets, was noted as a potential area for impairment risk.

ELV 10-K FY2006 Annual Report — Revenue, Net Income, EPS

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported a strong financial performance for the fiscal year ending December 31, 2006. The company experienced significant revenue growth, primarily driven by the acquisition of WellChoice, Inc. and organic growth across its various product lines. Management highlighted a 22% increase in diluted earnings per share (EPS), exceeding their growth target. The company continued its strategy of profitable enrollment growth, disciplined pricing, cost optimization, and effective cash flow utilization. Elevance Health remains focused on expanding its market presence through both organic growth and strategic acquisitions, emphasizing geographic diversity and leveraging its strong Blue Cross and Blue Shield brand recognition. The company's diversified membership base, spanning commercial, individual, senior, and government markets, positions it well to navigate the evolving healthcare landscape. Financial stability was demonstrated through robust cash flow generation and a healthy balance sheet, supported by significant stock repurchase programs and a strong debt rating. Key initiatives like the 360º Health program and participation in the Blue Health Intelligence database underscore the company's commitment to improving care quality and member experience.

Key Highlights

1Total operating revenue grew 28% year-over-year to $56.1 billion, primarily due to the WellChoice acquisition and premium rate increases.
2Diluted earnings per share (EPS) increased by 22% compared to the prior year, surpassing management's growth target.
3The company successfully managed its benefit expense ratio, keeping it at 81.2% while navigating increased healthcare costs.
4WellPoint (Elevance Health) repurchased approximately 60.7 million shares of its common stock for $4.6 billion during 2006, demonstrating a commitment to returning capital to shareholders.
5Membership increased by 1% to 34.1 million, driven by growth in BlueCard and National Accounts, partially offset by losses in specific large group accounts.
6The company's significant investment in technology and e-business strategies aims to enhance customer interactions and operational efficiency.
7Elevance Health maintained a strong financial position with $20.8 billion in cash, cash equivalents, and investments as of December 31, 2006.

Elevance Health, Inc. Annual Report, Year Ended Dec 31, 2006

Summary

Key Highlights

Frequently Asked Questions